background: there is a long lasting dilemma over the ideal screening and diagnostic method in gestational diabetes mellitus (gdm). even though universal screening is commonly practiced, selective screening based on risk factors is also practiced in some center. the aim of this study is to evaluate the most appropriate method to screen gdm in high‑risk pregnant women in sri lanka. methods: this ...

Background Accurate, simple and non-invasive tools are needed for efficient screening of abnormal glucose tolerance (AGT) and educating the general public. Aim To develop a neural network-based initial screening and educational model for AGT. Data and methods 230 subjects with AGT and 3,243 subjects with normal glucose tolerance (NGT) were allocated into training, validation and test sets using...

AIM The present study was aimed to assess the fasting and postprandial gingival crevicular blood (GCB) glucose and finger stick blood glucose measurements using a glucometer. MATERIALS AND METHODS A total of 30 subjects with periodontitis and positive bleeding on probing were considered. Subjects were instructed to report to the department after overnight fasting. Gingival crevicular blood sa...

Generally, assessment of fasting glucose is recommended as screening and monitoring for diabetes (ADA/APA consensus, 2004) although an Oral Glucose Tolerance Test (OGTT) remains the gold standard (Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003). HbA1c is accepted as a useful index of mean blood glucose levels in the treatment of patients with diabetes but was no...

OBJECTIVES (a) To test the sensitivity and specificity of measuring fasting plasma glucose levels (FPG) as a screening test for gestational diabetes mellitus (GDM). (b) To compare predicting levels of FPG levels with the one-hour, oral 50g non-fasting glucose challenge test (GCT) for predicting GDM. METHODS One thousand and six hundred pregnant women from the Health Centres, antenatal clinics...

Background: Computerized preventive screening software is a cost effective intervention tool to address non-communicable chronic diseases. Shiraz Smart Screening Software (SSSS) was developed as an innovative tool for qualified screening. It allows simultaneous smart screening of several high-burden chronic diseases and supports reminder notification functionality. The extent in which SSSS affe...

mexico, like many low- and middle-income countries (lmics), faces an epidemic of chronic non-communicable diseases (ncds), specifically diabetes, hypertension, obesity, and lipid disorders. many people with these ncds may not be aware that they have a disease, pointing to the need for broader screening programs. the traditional prevention policy in mexico was based on screening with a paper-bas...